Just to add to the above post, I had a quick look at what Napp Pharmaceuticals do, because Pharmas don’t usually do these studies unless it relates to their products.
What a surprise, looks like they are the UK distributor of Janssen’s Invokana:
https://napp.co.uk
one of the external link diabetes websites they maintain. Happy to see that the CVD & CKD outcomes are listed there on their UK website:
https://www.invokana.co.uk/why-chose-invokana/cardiovascular-renal-outcomes/
Interesting.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.015(4.92%) |
Mkt cap ! $47.42M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 28.5¢ | $191.2K | 643.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 53694 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 51000 | 2 |
View Market Depth
| Last trade - 15.36pm 26/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |